Cargando…

Surface-modified gatifloxacin nanoparticles with potential for treating central nervous system tuberculosis

A new nanocarrier is developed for the passage of gatifloxacin through the blood–brain barrier to treat central nervous system tuberculosis. Gatifloxacin nanoparticles were prepared by nanoprecipitation using poly(lactic-co-glycolic acid) (PLGA) 502 and polysorbate 80 or Labrafil as surface modifier...

Descripción completa

Detalles Bibliográficos
Autores principales:	Marcianes, Patricia, Negro, Sofia, García-García, Luis, Montejo, Consuelo, Barcia, Emilia, Fernández-Carballido, Ana
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2017
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5357078/ https://www.ncbi.nlm.nih.gov/pubmed/28331318 http://dx.doi.org/10.2147/IJN.S130908

Ejemplares similares

Functionalization of Morin-Loaded PLGA Nanoparticles with Phenylalanine Dipeptide Targeting the Brain
por: Alonso, Mario, et al.
Publicado: (2022)

Sulfasalazine Microparticles Targeting Macrophages for the Treatment of Inflammatory Diseases Affecting the Synovial Cavity
por: Villa-Hermosilla, Monica-Carolina, et al.
Publicado: (2021)

Celecoxib Microparticles for Inhalation in COVID-19-Related Acute Respiratory Distress Syndrome
por: Villa-Hermosilla, Monica-Carolina, et al.
Publicado: (2022)

Nanotechnology-based drug delivery of ropinirole for Parkinson’s disease
por: Barcia, Emilia, et al.
Publicado: (2017)

Micro- and Nano-Systems Developed for Tolcapone in Parkinson’s Disease
por: Casanova, Yaquelyn, et al.
Publicado: (2022)

Moxifloxacin and gatifloxacin for initial therapy of tuberculosis: a meta-analysis of randomized clinical trials
por: Ruan, Qiaoling, et al.
Publicado: (2016)

Efficacy of Gatifloxacin in Acute Bacterial Corneal ulcer
por: Afzal Junejo, Sameen, et al.
Publicado: (2013)

Effects on the QT Interval of a Gatifloxacin-Containing Regimen versus Standard Treatment of Pulmonary Tuberculosis
por: Olliaro, Piero L., et al.
Publicado: (2017)

Synthesis and Characterization of Potential Dimers of Gatifloxacin – an Antibacterial Drug
por: Garaga, Srinivas, et al.
Publicado: (2013)

Ultrasound-assisted gatifloxacin delivery in mouse cornea, in vivo
por: Jegal, Uk, et al.
Publicado: (2019)

Au nanoparticle sensitized blue TiO(2) nanorod arrays for efficient Gatifloxacin photodegradation
por: Guo, Jun, et al.
Publicado: (2023)

Immunology and the Central Nervous System
por: Barcia, Carlos, et al.
Publicado: (2013)

Nanoparticle delivery through the BBB in central nervous system tuberculosis
por: Griego, Anna, et al.
Publicado: (2023)

Preparation and in vitro antibacterial evaluation of gatifloxacin mucoadhesive gellan system
por: Kesavan, K., et al.
Publicado: (2010)

Clinical use of gatifloxacin ophthalmic solution for treatment of bacterial conjunctivitis
por: Cervantes, Lorenzo J, et al.
Publicado: (2011)

Intraocular penetration of sequentially instilled topical moxifloxacin, gatifloxacin, and levofloxacin
por: Sugioka, Koji, et al.
Publicado: (2009)

Ocular insert for sustained delivery of gatifloxacin sesquihydrate: Preparation and evaluations
por: Khurana, Gaurav, et al.
Publicado: (2012)

Gatifloxacin Loaded Nano Lipid Carriers for the Management of Bacterial Conjunctivitis
por: Joshi, Poorva H., et al.
Publicado: (2023)

Comparing efficacies of moxifloxacin, levofloxacin and gatifloxacin in tuberculosis granulomas using a multi-scale systems pharmacology approach
por: Pienaar, Elsje, et al.
Publicado: (2017)

Comparison of Drug Concentrations in Human Aqueous Humor after the Administration of 0.3% Gatifloxacin Ophthalmic Gel, 0.3% Gatifloxacin and 0.5% Levofloxacin Ophthalmic Solutions
por: Ding, Wenting, et al.
Publicado: (2015)

A novel gatifloxacin-loaded intraocular lens for prophylaxis of postoperative endophthalmitis
por: Li, Mengna, et al.
Publicado: (2022)

The treatment effect of Levofloxacin, Moxifloxacin, and Gatifloxacin contained in the conventional therapy regimen for pulmonary tuberculosis: Systematic review and network meta-analysis
por: He, Yiyue, et al.
Publicado: (2022)

An Open Randomized Comparison of Gatifloxacin versus Cefixime for the Treatment of Uncomplicated Enteric Fever
por: Pandit, Anil, et al.
Publicado: (2007)

Concentrations of besifloxacin, gatifloxacin, and moxifloxacin in human conjunctiva after topical ocular administration
por: Torkildsen, Gail, et al.
Publicado: (2010)

Effect of gatifloxacin against Mycoplasma genitalium-related urethritis: an open clinical trial
por: Hamasuna, Ryoichi, et al.
Publicado: (2011)

Sodium Alginate Based Mucoadhesive System for Gatifloxacin and Its In Vitro Antibacterial Activity
por: Kesavan, Karthikeyan, et al.
Publicado: (2010)

Gatifloxacin Ophthalmic Solution for Treatment of Bacterial Conjunctivitis: Safety, Efficacy and Patient Perspective
por: Schultz, Clyde
Publicado: (2012)

Bilayered Films Based on Novel Polymer Derivative for Improved Ocular Therapy of Gatifloxacin
por: Aher, Naval Dinesh, et al.
Publicado: (2014)

Antiparkinsonian Agents in Investigational Polymeric Micro- and Nano-Systems
por: Paccione, Nicola, et al.
Publicado: (2022)

Gatifloxacin versus chloramphenicol for uncomplicated enteric fever: an open-label, randomised, controlled trial
por: Arjyal, Amit, et al.
Publicado: (2011)

Angiopep-2 Modified Exosomes Load Rifampicin with Potential for Treating Central Nervous System Tuberculosis
por: Li, Han, et al.
Publicado: (2023)

Randomized Clinical Trial of Thrice-Weekly 4-Month Moxifloxacin or Gatifloxacin Containing Regimens in the Treatment of New Sputum Positive Pulmonary Tuberculosis Patients
por: Jawahar, Mohideen S., et al.
Publicado: (2013)

Central Nervous System Tuberculosis – The Gray Area in Tuberculosis Treatment
por: James, Joe
Publicado: (2019)

Diagnostic Challenges of Central Nervous System Tuberculosis
por: Christie, Laura J., et al.
Publicado: (2008)

Efficacy and tolerability of a combined gatifloxacin plus prednisolone formulation for topical prophylaxis after LASIK
por: Campos, Mauro, et al.
Publicado: (2011)

Experimental and theoretical studies on the molecular properties of ciprofloxacin, norfloxacin, pefloxacin, sparfloxacin, and gatifloxacin in determining bioavailability
por: Kłosińska-Szmurło, E., et al.
Publicado: (2014)

In vivo 3D measurement of moxifloxacin and gatifloxacin distributions in the mouse cornea using multiphoton microscopy
por: Lee, Seunghun, et al.
Publicado: (2016)

Dissipation Dynamics of Doxycycline and Gatifloxacin and Accumulation of Heavy Metals during Broiler Manure Aerobic Composting
por: Chu, Lei, et al.
Publicado: (2021)

Design of a Controlled-Release Delivery Composite of Antibacterial Agent Gatifloxacin by Spherical Silica Nanocarrier
por: Guo, Xueping, et al.
Publicado: (2022)

Comparative Study of Ocular Pharmacokinetics of Topical 0.3% Gatifloxacin Eye Gel and Solution in Rabbits
por: Liu, Manli, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_9jjteb4onusk507kjj6jrkp07h